Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gleave

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
European Urology|February 12, 2009
Re: Cumulative association of five genetic variants with prostate cancerMartin Gleave
European Urology|June 18, 2013
Prime time for intermittent androgen suppressionMartin Gleave
Annals of the New York Academy of Sciences|January 31, 2004
Clusterin and IGFBPs as antisense targets in prostate cancerMartin Gleave, Burkhard Jansen
The Journal of Urology|December 20, 2016
Re: Robotic versus Open Prostatectomy: End of the Controversy: M. O. Koch J Urol 2016;196:9-10Christian Stief, Martin Gleave
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 19, 2010
Ensuring quality for radical prostatectomies in CanadaAnthony Koupparis, Martin Gleave
European Urology|August 25, 2014
Toward predictive signatures of enzalutamide response and resistanceMartin Gleave, Kim Chi
International Journal of Urology : Official Journal of the Japanese Urological Association|January 12, 2013
Radical prostatectomy in high-risk prostate cancerJoseph Ischia, Martin Gleave
The International Journal of Biochemistry & Cell Biology|May 11, 2012
Small heat shock proteins in cancer therapy and prognosisAmina Zoubeidi, Martin Gleave
World Journal of Urology|March 17, 2005
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancerMartin Gleave, Hideaki Miyake
Annals of the New York Academy of Sciences|January 6, 2006
Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancersMartin Gleave, Kim N Chi
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
European Urology|February 12, 2009
Re: Cumulative association of five genetic variants with prostate cancerMartin Gleave
European Urology|June 18, 2013
Prime time for intermittent androgen suppressionMartin Gleave
Annals of the New York Academy of Sciences|January 31, 2004
Clusterin and IGFBPs as antisense targets in prostate cancerMartin Gleave, Burkhard Jansen
The Journal of Urology|December 20, 2016
Re: Robotic versus Open Prostatectomy: End of the Controversy: M. O. Koch J Urol 2016;196:9-10Christian Stief, Martin Gleave
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 19, 2010
Ensuring quality for radical prostatectomies in CanadaAnthony Koupparis, Martin Gleave
European Urology|August 25, 2014
Toward predictive signatures of enzalutamide response and resistanceMartin Gleave, Kim Chi
International Journal of Urology : Official Journal of the Japanese Urological Association|January 12, 2013
Radical prostatectomy in high-risk prostate cancerJoseph Ischia, Martin Gleave
The International Journal of Biochemistry & Cell Biology|May 11, 2012
Small heat shock proteins in cancer therapy and prognosisAmina Zoubeidi, Martin Gleave
World Journal of Urology|March 17, 2005
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancerMartin Gleave, Hideaki Miyake
Annals of the New York Academy of Sciences|January 6, 2006
Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancersMartin Gleave, Kim N Chi
Pageof 26